Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...